JPS62275456A - Wound protective material - Google Patents
Wound protective materialInfo
- Publication number
- JPS62275456A JPS62275456A JP11608086A JP11608086A JPS62275456A JP S62275456 A JPS62275456 A JP S62275456A JP 11608086 A JP11608086 A JP 11608086A JP 11608086 A JP11608086 A JP 11608086A JP S62275456 A JPS62275456 A JP S62275456A
- Authority
- JP
- Japan
- Prior art keywords
- wound
- protection material
- water
- deposited
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000463 material Substances 0.000 title claims description 23
- 230000001681 protective effect Effects 0.000 title 1
- 239000000835 fiber Substances 0.000 claims description 26
- 210000001124 body fluid Anatomy 0.000 claims description 9
- 239000010839 body fluid Substances 0.000 claims description 9
- 239000005871 repellent Substances 0.000 claims description 9
- 229910052751 metal Inorganic materials 0.000 claims description 7
- 239000002184 metal Substances 0.000 claims description 7
- 208000027418 Wounds and injury Diseases 0.000 description 46
- 206010052428 Wound Diseases 0.000 description 45
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 239000000853 adhesive Substances 0.000 description 9
- 230000001070 adhesive effect Effects 0.000 description 9
- 229920000742 Cotton Polymers 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- -1 if Chemical compound 0.000 description 5
- 239000011148 porous material Substances 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000004744 fabric Substances 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 229920000728 polyester Polymers 0.000 description 4
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 4
- 230000006378 damage Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000004745 nonwoven fabric Substances 0.000 description 3
- 230000029663 wound healing Effects 0.000 description 3
- 239000002759 woven fabric Substances 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 241000283977 Oryctolagus Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000000151 deposition Methods 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920006254 polymer film Polymers 0.000 description 2
- 229960005205 prednisolone Drugs 0.000 description 2
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229910001961 silver nitrate Inorganic materials 0.000 description 2
- 239000012209 synthetic fiber Substances 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 230000037314 wound repair Effects 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- FFTVPQUHLQBXQZ-KVUCHLLUSA-N (4s,4as,5ar,12ar)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1C2=C(N(C)C)C=CC(O)=C2C(O)=C2[C@@H]1C[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O FFTVPQUHLQBXQZ-KVUCHLLUSA-N 0.000 description 1
- LEBVLXFERQHONN-UHFFFAOYSA-N 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Chemical compound CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-UHFFFAOYSA-N 0.000 description 1
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- SPCKHVPPRJWQRZ-UHFFFAOYSA-N 2-benzhydryloxy-n,n-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 SPCKHVPPRJWQRZ-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- IYLLULUTZPKQBW-UHFFFAOYSA-N Acrinol Chemical compound CC(O)C(O)=O.C1=C(N)C=CC2=C(N)C3=CC(OCC)=CC=C3N=C21 IYLLULUTZPKQBW-UHFFFAOYSA-N 0.000 description 1
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 1
- 108010001478 Bacitracin Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 208000035874 Excoriation Diseases 0.000 description 1
- AGJUUQSLGVCRQA-SWOUQTJZSA-N Fungichromin Chemical compound CCCCC[C@@H](O)[C@@H]1[C@@H](O)C[C@@H](O)C[C@@H](O)C[C@@H](O)C[C@@H](O)C[C@@H](O)[C@@H](O)[C@H](O)\C(C)=C\C=C\C=C\C=C\C=C\[C@H](O)[C@@H](C)OC1=O AGJUUQSLGVCRQA-SWOUQTJZSA-N 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- ZBBHBTPTTSWHBA-UHFFFAOYSA-N Nicardipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)CC=2C=CC=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 ZBBHBTPTTSWHBA-UHFFFAOYSA-N 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- AGJUUQSLGVCRQA-UHFFFAOYSA-N Pentamycin Natural products CCCCCC(O)C1C(O)CC(O)CC(O)CC(O)CC(O)CC(O)C(O)C(O)C(C)=CC=CC=CC=CC=CC(O)C(C)OC1=O AGJUUQSLGVCRQA-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920000153 Povidone-iodine Polymers 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- ATMLPEJAVWINOF-UHFFFAOYSA-N acrylic acid acrylic acid Chemical compound OC(=O)C=C.OC(=O)C=C ATMLPEJAVWINOF-UHFFFAOYSA-N 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229960003071 bacitracin Drugs 0.000 description 1
- 229930184125 bacitracin Natural products 0.000 description 1
- CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 description 1
- 229960005274 benzocaine Drugs 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- 229960004311 betamethasone valerate Drugs 0.000 description 1
- SNHRLVCMMWUAJD-SUYDQAKGSA-N betamethasone valerate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(OC(=O)CCCC)[C@@]1(C)C[C@@H]2O SNHRLVCMMWUAJD-SUYDQAKGSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- ALEXXDVDDISNDU-JZYPGELDSA-N cortisol 21-acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)C[C@@H]2O ALEXXDVDDISNDU-JZYPGELDSA-N 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960000520 diphenhydramine Drugs 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 229960000308 fosfomycin Drugs 0.000 description 1
- YMDXZJFXQJVXBF-STHAYSLISA-N fosfomycin Chemical compound C[C@@H]1O[C@@H]1P(O)(O)=O YMDXZJFXQJVXBF-STHAYSLISA-N 0.000 description 1
- PGBHMTALBVVCIT-VCIWKGPPSA-N framycetin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)O[C@@H]1CO PGBHMTALBVVCIT-VCIWKGPPSA-N 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 239000002874 hemostatic agent Substances 0.000 description 1
- 229960001067 hydrocortisone acetate Drugs 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 229960002523 mercuric chloride Drugs 0.000 description 1
- LWJROJCJINYWOX-UHFFFAOYSA-L mercury dichloride Chemical compound Cl[Hg]Cl LWJROJCJINYWOX-UHFFFAOYSA-L 0.000 description 1
- 229960003085 meticillin Drugs 0.000 description 1
- 229960004023 minocycline Drugs 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 229960001783 nicardipine Drugs 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
- 229960001597 nifedipine Drugs 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- OGJPXUAPXNRGGI-UHFFFAOYSA-N norfloxacin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 OGJPXUAPXNRGGI-UHFFFAOYSA-N 0.000 description 1
- 229960001180 norfloxacin Drugs 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229960000339 pentamycin Drugs 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229960002702 piroxicam Drugs 0.000 description 1
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 229920005672 polyolefin resin Polymers 0.000 description 1
- 229920005749 polyurethane resin Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229960001621 povidone-iodine Drugs 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- VACCAVUAMIDAGB-UHFFFAOYSA-N sulfamethizole Chemical compound S1C(C)=NN=C1NS(=O)(=O)C1=CC=C(N)C=C1 VACCAVUAMIDAGB-UHFFFAOYSA-N 0.000 description 1
- 229960005158 sulfamethizole Drugs 0.000 description 1
- 229920003051 synthetic elastomer Polymers 0.000 description 1
- 239000005061 synthetic rubber Substances 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229950010298 tinoridine Drugs 0.000 description 1
- PFENFDGYVLAFBR-UHFFFAOYSA-N tinoridine Chemical compound C1CC=2C(C(=O)OCC)=C(N)SC=2CN1CC1=CC=CC=C1 PFENFDGYVLAFBR-UHFFFAOYSA-N 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Landscapes
- Secondary Cells (AREA)
- Insulation, Fastening Of Motor, Generator Windings (AREA)
- Cable Accessories (AREA)
Abstract
(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.
Description
【発明の詳細な説明】
3、発明の詳細な説明
〈産業上のゼj用分野〉
本発明は撥水性を有I−且つ創傷部に固着1−に<(、
創傷部修復治癒を著(7(助長する創傷保護材に関する
。更に詳細には、金属を蒸着させた繊維集合体7体液を
吸収するためのFR,維集合体及び撥水性を有する微多
孔質ツー〔ルムから主としてなる、創傷部の修復治癒を
著(7く助長する創傷保護材に関する。Detailed Description of the Invention 3. Detailed Description of the Invention (Industrial Field) The present invention provides water repellency and adhesion to a wound.
Relating to a wound protection material that promotes wound repair and healing. [This article relates to a wound protection material that is mainly composed of lume and promotes repair and healing of a wound.
〈従来の技術〉
創傷部は火傷、物理的傷害、皮膚剥離などによって起生
されるが、これらを治療する場合、例えば創傷部に硝酸
銀や局所抗生剤などの治療薬を塗布し、その上に薬用ガ
ーゼを当ててその上から包帯を巻くか、又は薬用ガーゼ
に治gl薬を塗布し、それらを創傷部に当て、その上か
ら包帯を巻(方法等が採ちれている。<Prior art> Wounds are caused by burns, physical injuries, skin peeling, etc. When treating these, for example, a therapeutic agent such as silver nitrate or a topical antibiotic is applied to the wound, and then Methods such as applying medicated gauze and wrapping a bandage over it, or applying a therapeutic agent to medicated gauze, applying it to the wound, and then wrapping a bandage over it are adopted.
1、かしこれらの方法では、創傷部の血液、膿等により
薬用ガーゼが創傷部に固着して1.まい薬用ガーゼを剥
す際に薬用ガーゼの固着I、た創傷部の皮膚(カサゲタ
等)が−緒に剥れてしまい創傷部を傷めてしまうという
欠点があった。1. However, in these methods, the medicated gauze sticks to the wound due to blood, pus, etc. in the wound. When the medicated gauze is removed, the medicated gauze sticks and the skin (scabs, etc.) on the wound area peels off, causing damage to the wound area.
又包帯は通常、ガーゼによってつくられており水を吸収
するため水と接触すると患部がぬれ、細菌の流入、繁殖
などの原因どなり本来傷口を守るべき包帯が逆効果にな
るという欠点があった。In addition, bandages are usually made of gauze, which absorbs water, so when they come into contact with water, the affected area gets wet, which can lead to the influx and proliferation of bacteria, making the bandage, which is supposed to protect the wound, counterproductive.
近年これらの欠点を改善するため、例えば特開昭58−
20935号公報に見られるようK、薬用ガーゼの片面
に金属を蒸着せ(、め、傷口に固着することの無い薬用
ガーゼとする方法や、時開昭59−181158号公報
に見られるように外部からの水又は細菌類の侵入を防止
した、撥水性を有する微多孔質フィルムを用いた創傷カ
バー剤などが提案されている。1−か(7この両者を兼
ねそろえた創傷保護材は提案されていなかった。In recent years, in order to improve these shortcomings, for example, Japanese Patent Application Laid-open No.
As seen in Publication No. 20935, there is a method of vapor-depositing a metal on one side of medicated gauze to make medicated gauze that does not stick to the wound, and as seen in Publication No. 181158/1980, there is a method of depositing metal on one side of medicated gauze. Wound coverings using water-repellent, microporous films that prevent water or bacteria from entering have been proposed. It wasn't.
〈発明が解決(、ようとする問題点〉
本発明者らは創傷部の修復治癒速度が速い優れた創傷保
護材の構造について鋭意検討1.た結果、撥水性を有す
る微多孔質フィルム、体液を吸収する為の繊維集合体、
及びアルミニウム蒸着(、た繊維集合体からなる創傷保
護材は、著しく創傷部の修復治癒を助長するという驚(
べき事実を見出し1本発明に至った。<Problems to be solved by the invention> The present inventors have conducted intensive studies on the structure of an excellent wound protection material that can repair and heal wounds quickly. fiber aggregate for absorbing
It is surprising that a wound protection material made of aluminum-deposited and aluminum-deposited fiber aggregates significantly promotes repair and healing of the wound.
The present invention was achieved by discovering this fact.
〈問題点を解決するための手段〉
即ち、本発明は金属を蒸着させた繊維集合体体液なg!
に収するための!R維集合体、及び撥水性を有する微多
孔質フィルムから主としてなることを特徴とする創傷保
護材である。<Means for Solving the Problems> That is, the present invention provides a body fluid made of fiber aggregates on which metal is vapor-deposited.
To fit in! This is a wound protection material mainly consisting of R fiber aggregates and a water-repellent microporous film.
本発明の創傷保護材を構成する金属を蒸着させた繊維集
合体に用いるf&維は、通常用いられるいかなるもので
あってもよ(、その具体例としては、木綿、綿等の天然
繊維やポリニステルルセルロースエステル等の合成繊維
などの繊維を織布、不織布1編物等の形態としたものな
どがJ挙げられる。本発明ではかかる繊維集合体の片面
あるいは両面に例えば金、白金、銀、バランウム、アル
ミニウム、チタン、銅、 if 、 ニッケル、亜鉛、
それらの合金、ステンレス鋼等のいずれか一種または二
徨以上を蒸着させたものを用いる。かかる繊維集合体は
創傷部から発生する血液や膿が凝固しても金属蒸着面と
創傷部が固着することがない性質を有する。The f&fiber used in the metal-deposited fiber aggregate constituting the wound protection material of the present invention may be of any commonly used type (specific examples include natural fibers such as cotton and cotton, and polyester fibers). Examples include fibers such as synthetic fibers such as Nysterle cellulose ester in the form of woven fabrics, non-woven fabrics, and knitted fabrics.In the present invention, gold, platinum, silver, balanum, etc. are coated on one or both sides of such fiber aggregates. , aluminum, titanium, copper, if , nickel, zinc,
A material on which one or more of these alloys, stainless steel, etc. is deposited is used. Such a fiber aggregate has a property that the metal-deposited surface and the wound part do not stick together even if blood or pus generated from the wound part coagulates.
本発明の体液を吸収するための繊維集合体とは創傷部か
ら出る体液を吸収するものであれば特に制限されず、そ
の具体例として木M、綿等の天然HR維やポリエステル
、セルロースエステル等の合成繊維などの繊維をそのま
ま面状にしたものや織布、不織布、編物等の形態にした
ものが挙げられる。The fiber aggregate for absorbing body fluids according to the present invention is not particularly limited as long as it absorbs body fluids coming out of a wound, and specific examples thereof include natural HR fibers such as wood M, cotton, polyester, cellulose ester, etc. Examples include synthetic fibers and other fibers made into planar shapes as they are, and those made into woven fabrics, nonwoven fabrics, knitted fabrics, and the like.
本発明の撥水性を有する微多孔質フィルムとは、外部か
ら水や細菌などを侵入させず、しかも創傷部の面の湿分
を放出させるに充分な孔径を有する微孔を無数に有する
ものであって1例えば微孔性フッ素樹脂フィルム、微孔
性ポリウレタン樹脂フィルム、微孔性ポリオレフィン樹
脂フィルム、微孔性ポリアミドフィルム、微孔性ポリス
ルホン樹脂フィルムなどの微多孔性高分子フィルムが用
いられる。微多孔性高分子フィルムにおける微孔の孔径
は1通常100A”〜100μm、好ましくは1000
久〜lOμmの範囲であって、100A以下では湿分の
蒸散を阻害するために好ましくな(,100μm以上で
は水などが侵入するために好ましくないものである。勿
論孔径のみでなく、いわゆる空孔率も重要な因子であり
1通常5〜90%、好ましくは20〜85チ程度である
。The water-repellent microporous film of the present invention is one that has countless micropores that do not allow water or bacteria to enter from the outside and have a sufficient pore size to release moisture from the wound surface. For example, microporous polymer films such as microporous fluororesin films, microporous polyurethane resin films, microporous polyolefin resin films, microporous polyamide films, and microporous polysulfone resin films are used. The pore diameter of the micropores in the microporous polymer film is usually 100A'' to 100μm, preferably 1000μm.
It is in the range of 10 μm to 10 μm, and 100 A or less is preferable because it inhibits moisture evaporation (and 100 μm or more is unfavorable because water etc. enter. Of course, it is not only the pore size that is important, but also the so-called pore size). The ratio is also an important factor and is usually about 5 to 90%, preferably about 20 to 85%.
これらの微多孔性フィルム状のものの他、不織布状、織
物、451物性9紙状面状体と合一せしめたものも含ま
れる。また微多孔質フィルムは、透湿性9通気性を有す
るものが好ましい。In addition to these microporous film forms, non-woven fabrics, woven fabrics, and those combined with 451 Physical Properties 9 paper-like planar bodies are also included. Further, the microporous film preferably has moisture permeability and air permeability.
本発明の創傷保護材は、通常撥水性を有する微多孔質フ
ィルム、次いで体液を吸収するための繊維集合体、次い
で金属を蒸着させた繊H1集合体の順に積層して得られ
る。The wound protection material of the present invention is usually obtained by laminating in this order a water-repellent microporous film, a fiber aggregate for absorbing body fluids, and then a metal-deposited fiber H1 aggregate.
このように金属を蒸着させた繊維集合体1体液を吸収す
るための繊維集合体及び撥水性を有する微多孔質フィル
ムとを主として複合してなる創傷保護材には必g!に応
じて、金属を蒸着させた繊維集合体9体液を吸収するた
めの繊維集合体に薬物を配合して、創傷治癒の促進効果
を期待するのも本発明の〜態様である。かかる薬物の例
としては、例えばペニシリン、テトラサイクリン、ゲン
タマイシン、フラジオマイシン。This is a must-have for wound protection materials that are mainly composed of a metal-deposited fiber aggregate, a fiber aggregate for absorbing body fluids, and a water-repellent microporous film! In accordance with this, it is also an aspect of the present invention to incorporate a drug into the metal-deposited fiber assembly 9 for absorbing body fluids, in order to expect the effect of promoting wound healing. Examples of such drugs are eg penicillin, tetracycline, gentamicin, fradiomycin.
バシトラシン、ホスホマイシン、ミノサイクリン、メチ
シリン、ノルフロキサシン等の抗生物質や化学療法剤;
ヒドロフルチジン、酢酸ヒドロコルチゾンプレドニゾロ
ン、デキサメサゾン。Antibiotics and chemotherapeutic agents such as bacitracin, fosfomycin, minocycline, methicillin, norfloxacin;
Hydroflutidine, hydrocortisone acetate, prednisolone, dexamethasone.
吉草酸ベタメサゾン等の副腎皮質ホルモン剤;ヨウ素、
ポビドンヨード、アクリノール塩化第二水銀、硝酸銀、
マキュpコpム、スルファメチゾール、ペンタマイシン
、ミフナゾール、トリフマイシン、塩酸シマゾール等の
抗菌もしくは抗真菌剤;リドカイン、ペンシカイン、ア
ミノ安息香酸エチル、塩酸ブpカイン、ンブロカイン、
プロ力イン等の局所麻酔剤;7スビリン。Corticosteroids such as betamethasone valerate; iodine;
povidone iodine, acrinol mercuric chloride, silver nitrate,
Antibacterial or antifungal agents such as Macup Copm, Sulfamethizole, Pentamycin, Mifnazole, Trifmycin, Cimazole Hydrochloride; Lidocaine, Pensicaine, Ethyl Aminobenzoate, Bucaine Hydrochloride, Nbrocaine,
Local anesthetics such as Procotylin; 7 Subirin.
サリチル酸、サリチル酸l−メントール、7ミノビリン
、フェニルフ゛タゾン、カブサイシン。Salicylic acid, l-menthol salicylate, 7-minovirine, phenylphytazone, cabsaicin.
ピロキシカム、インドメタシン、グ?ヤ7ズレン、ケト
プロフエンフエングエン、塩酸チノリジン、プレドニゾ
ロン並びにこれらの誘導体等の消炎鎮痛剤もしくは皮膚
疾患用剤;ジフェンヒドラミン、塩酸ジフェンヒドラミ
ン等の抗ヒスタミン剤;ニド−グリセリン、硝酸インソ
ルビド、ニフェジピン、ニカルジピン等の冠血管拡張剤
;フンドロイチン硫酸、ヒアルロン硫酸等のムコ多糖類
;トラネキサム酸等の止血剤など挙げられ、これらの使
用は一覆もしくは二種以上であってよい。Piroxicam, indomethacin, g? Anti-inflammatory analgesics or agents for skin diseases such as Ya7zuren, ketoprofenfuenguen, tinoridine hydrochloride, prednisolone, and their derivatives; antihistamines such as diphenhydramine, diphenhydramine hydrochloride; drugs such as nido-glycerin, insorbide nitrate, nifedipine, nicardipine, etc. Vasodilators; mucopolysaccharides such as fundroitin sulfate and hyaluronic sulfate; hemostatic agents such as tranexamic acid; and the like, and these may be used in combination or in combination of two or more.
本発明による創傷保護材は所望形状に切rrtて創傷部
位に外用接着テープで固定するか或いは予め創傷保護材
片の主として周辺部に例えばl[縁状に粘着剤を形成し
ておいて固定するなどして用いられる。The wound protection material according to the present invention can be cut into a desired shape and fixed to the wound site with external adhesive tape, or it can be fixed by forming an adhesive in the form of an edge, for example, on the main periphery of the wound protection material piece in advance. It is used as such.
かかる粘着剤としては、アクリル酸ニスデル−アクリル
酸共重合体系、エチルンー酢酸ビニル共重合体系、アク
リル酸エステル系、ポリブテン系、ポリビニルアルコー
ル、天然ゴム合成ゴム等が使用できる。As such adhesives, Nisder acrylate-acrylic acid copolymer systems, ethyl-vinyl acetate copolymer systems, acrylic ester systems, polybutene systems, polyvinyl alcohols, natural rubbers, synthetic rubbers, etc. can be used.
これらの粘着剤は、それ自身皮膚に対して無刺激である
ことが必要とされろ。また、皮膚面に対し、軽い圧力で
接着しかつまた。普通の活動にては、充分皮膚に保持さ
れる程度の粘着力を必要とする。さらに創傷保護材をA
lj促部位より取り去るとき、皮ffK粘着剤が残った
り痛み感を与えないものが好ましい。These adhesives themselves need to be non-irritating to the skin. It also adheres to the skin surface with light pressure. Normal activities require sufficient adhesion to be retained on the skin. In addition, apply wound protection material A.
It is preferable that the adhesive does not leave any skin ffK adhesive or cause pain when removed from the lj-promoting area.
本発明の創傷保護材について図面に基いて説明する。図
は本発明の創傷保護材の一態様を示したものである。図
において、■は金属を蒸着せしめた繊維集合体、2は体
液を吸収するための繊維集合体、3は撥水性を有する微
多孔質フィルム、4は粘着剤である。The wound protection material of the present invention will be explained based on the drawings. The figure shows one embodiment of the wound protection material of the present invention. In the figure, ■ is a fiber aggregate on which metal is vapor-deposited, 2 is a fiber aggregate for absorbing body fluids, 3 is a water-repellent microporous film, and 4 is an adhesive.
〈発明の効果ン
以上に詳述した如き本発明の創傷保護材は、創傷部に固
着することがないため創傷部を傷めてしまうことがなく
、また外部からの水又は細菌類の浸入がない。更には創
傷部修復治癒を著しく助長する効果も有する。<Effects of the Invention> The wound protection material of the present invention as detailed above does not stick to the wound area, so it does not damage the wound area, and there is no infiltration of water or bacteria from the outside. . Furthermore, it also has the effect of significantly promoting wound repair and healing.
〈実施例〉
以下実施例を挙げて具体的に本発明を更に説明するが本
発明は実施例のみに限定されるものではない。<Examples> The present invention will be further specifically explained below with reference to Examples, but the present invention is not limited only to the Examples.
実施例及び比較例1.2
実施例として厚さ1100p、平均孔径1.Oμmの撥
水性を有する微多孔質フィルム(種水化学:セルボ7)
を453IIX4511111に切断し、縁から15m
内側まで額縁状に粘着剤(サイデン化学;サイピノール
AT−301)を塗布した。粘着剤が塗布されていない
部分に15mX15m角の脱脂綿を置き、その上から2
511I X 25 fl角の片面をアルミニウム蒸着
したポリエステルフィラメント布をかぶせ1図に示した
如き創傷保護材を作成した。Examples and Comparative Examples 1.2 As examples, the thickness was 1100p and the average pore diameter was 1. Microporous film with Oμm water repellency (Tanesui Kagaku: Cervo 7)
Cut into 453IIX4511111, 15m from the edge.
An adhesive (Siden Chemical; Cypinol AT-301) was applied to the inside in a frame shape. Place a 15m x 15m square piece of absorbent cotton on the area where the adhesive is not applied, and then
A wound protection material as shown in Figure 1 was prepared by covering one side of a 511I x 25 fl square piece with a polyester filament cloth coated with aluminum.
比較例−1として、実施例のアルミニウム蒸着をしたポ
リエステルフィラメント布を、薬用ガーゼに変えた以外
は実施例と同様の方法で。Comparative Example 1 was prepared in the same manner as in the example except that the aluminum-deposited polyester filament cloth of the example was replaced with medicated gauze.
金属を蒸着させた繊維集合体のない創傷保護材を作成し
た。We created a wound protection material without fiber aggregates that was coated with metal.
比較例−2として実施例の撥水性を有する微多孔質フィ
ルムを市販の絆創IF(三相・キリン社製、大きさ45
X 45 y )からガーゼ、脱脂綿を取り除き、シ
ートのみにしたものに変えた以外は実施例と同様の方法
で、撥水性を有する微多孔質フィルムのない創傷保護材
を作成した。As Comparative Example-2, the water-repellent microporous film of the example was used as a commercially available Kizoku IF (Sanso, manufactured by Kirin Co., Ltd., size 45
A wound protection material without a water-repellent microporous film was prepared in the same manner as in Example except that the gauze and absorbent cotton were removed from X 45 y ) and replaced with a sheet only.
実施例、比較例1,2で作成した創傷保護材を6羽の家
兎を用いて試験をした。The wound protection materials prepared in Examples and Comparative Examples 1 and 2 were tested using six domestic rabbits.
試験は、家兎の背部の毛を刈り、アルコールで消毒した
後、l cMX lα角、厚さ6nの皮膚剥離創傷部を
3ケ所作り、実施例、比較例−1゜2のサンプルをエチ
レンオキサイドガスにて滅菌処理して貼り付けた。この
状態で1日1回水道の水流中に30秒問おき、3,6.
12日後の創傷部の治癒状態及び創傷面への固着状態を
目視により観察した。結果は表IK示した通りである。In the test, after cutting the hair on the back of a domestic rabbit and disinfecting it with alcohol, three skin abrasion wounds with a l cMX lα angle and a thickness of 6 nm were made, and the samples of Example and Comparative Example -1゜2 were treated with ethylene oxide. It was sterilized with gas and pasted. In this state, soak in running water for 30 seconds once a day, 3, 6.
After 12 days, the state of healing of the wound and the state of adhesion to the wound surface were visually observed. The results are shown in Table IK.
表1から明らかなように、実施例の創傷保護材は著しく
創傷部の修復治癒を助長した。As is clear from Table 1, the wound protection material of the example significantly promoted repair and healing of the wound area.
図は、本発明の創傷保護材の一つの実施態様について、
その横断面を例示したものである。
図中、1は金属を蒸着させた繊維集合体、2は体液を吸
収するための繊維集合体、3は撥水性を有する微多孔質
フィル、4は粘着剤を表わす。
回The figure shows one embodiment of the wound protection material of the present invention.
This is an example of its cross section. In the figure, 1 represents a fiber aggregate on which metal is vapor-deposited, 2 represents a fiber aggregate for absorbing body fluids, 3 represents a microporous film having water repellency, and 4 represents an adhesive. times
Claims (1)
維集合体、及び撥水性を有する微多孔質フイルムから主
としてなることを特徴とする創傷保護材。A wound protection material mainly comprising a fiber aggregate on which a metal is vapor-deposited, a fiber aggregate for absorbing body fluids, and a water-repellent microporous film.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11608086A JPS62275456A (en) | 1986-05-22 | 1986-05-22 | Wound protective material |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11608086A JPS62275456A (en) | 1986-05-22 | 1986-05-22 | Wound protective material |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS62275456A true JPS62275456A (en) | 1987-11-30 |
Family
ID=14678216
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP11608086A Pending JPS62275456A (en) | 1986-05-22 | 1986-05-22 | Wound protective material |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS62275456A (en) |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01128121U (en) * | 1988-02-26 | 1989-09-01 | ||
JP2005168723A (en) * | 2003-12-10 | 2005-06-30 | Nissei Kk | Absorbent adhesive sheet |
JP2008212591A (en) * | 2007-02-28 | 2008-09-18 | Chuichi Kubo | Wound protecting and dressing material |
US20140330227A1 (en) | 2010-03-16 | 2014-11-06 | Kci Licensing, Inc. | Delivery-and-fluid-storage bridges for use with reduced-pressure systems |
JP2015501671A (en) * | 2011-11-15 | 2015-01-19 | ケーシーアイ ライセンシング インコーポレイテッド | Medical dressings, systems, and methods with thermally enhanced vapor transmission |
US20150119831A1 (en) | 2013-10-30 | 2015-04-30 | Kci Licensing, Inc. | Condensate absorbing and dissipating system |
JP2015536795A (en) * | 2012-12-18 | 2015-12-24 | シスタジェニックス ウンド マネージメント イーペー カンパニー ベスローテン ヴェンノーツハップSystagenix Wound Management IP Co.B.V. | Wound dressing with adhesive rim |
US9861532B2 (en) | 2011-12-16 | 2018-01-09 | Kci Licensing, Inc. | Releasable medical drapes |
US9925092B2 (en) | 2013-10-30 | 2018-03-27 | Kci Licensing, Inc. | Absorbent conduit and system |
US9956120B2 (en) | 2013-10-30 | 2018-05-01 | Kci Licensing, Inc. | Dressing with sealing and retention interface |
US10010656B2 (en) | 2008-03-05 | 2018-07-03 | Kci Licensing, Inc. | Dressing and method for applying reduced pressure to and collecting and storing fluid from a tissue site |
US10016544B2 (en) | 2013-10-30 | 2018-07-10 | Kci Licensing, Inc. | Dressing with differentially sized perforations |
US10299966B2 (en) | 2007-12-24 | 2019-05-28 | Kci Usa, Inc. | Reinforced adhesive backing sheet |
US10357406B2 (en) | 2011-04-15 | 2019-07-23 | Kci Usa, Inc. | Patterned silicone coating |
US10406266B2 (en) | 2014-05-02 | 2019-09-10 | Kci Licensing, Inc. | Fluid storage devices, systems, and methods |
US10561534B2 (en) | 2014-06-05 | 2020-02-18 | Kci Licensing, Inc. | Dressing with fluid acquisition and distribution characteristics |
US10568767B2 (en) | 2011-01-31 | 2020-02-25 | Kci Usa, Inc. | Silicone wound dressing laminate and method for making the same |
US10842707B2 (en) | 2012-11-16 | 2020-11-24 | Kci Licensing, Inc. | Medical drape with pattern adhesive layers and method of manufacturing same |
US10940047B2 (en) | 2011-12-16 | 2021-03-09 | Kci Licensing, Inc. | Sealing systems and methods employing a hybrid switchable drape |
US10946124B2 (en) | 2013-10-28 | 2021-03-16 | Kci Licensing, Inc. | Hybrid sealing tape |
US10973694B2 (en) | 2015-09-17 | 2021-04-13 | Kci Licensing, Inc. | Hybrid silicone and acrylic adhesive cover for use with wound treatment |
US11026844B2 (en) | 2014-03-03 | 2021-06-08 | Kci Licensing, Inc. | Low profile flexible pressure transmission conduit |
US11096830B2 (en) | 2015-09-01 | 2021-08-24 | Kci Licensing, Inc. | Dressing with increased apposition force |
US11246975B2 (en) | 2015-05-08 | 2022-02-15 | Kci Licensing, Inc. | Low acuity dressing with integral pump |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5218304A (en) * | 1975-08-01 | 1977-02-10 | Fujitsu Ltd | Magnetic record/play equipment |
JPS57153644A (en) * | 1981-02-13 | 1982-09-22 | Sumisu Ando Nefuyuu Ass Co Ltd | Protective material for wound part |
JPS6037319B2 (en) * | 1981-07-16 | 1985-08-26 | サンデン株式会社 | Scroll compressor |
-
1986
- 1986-05-22 JP JP11608086A patent/JPS62275456A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5218304A (en) * | 1975-08-01 | 1977-02-10 | Fujitsu Ltd | Magnetic record/play equipment |
JPS57153644A (en) * | 1981-02-13 | 1982-09-22 | Sumisu Ando Nefuyuu Ass Co Ltd | Protective material for wound part |
JPS6037319B2 (en) * | 1981-07-16 | 1985-08-26 | サンデン株式会社 | Scroll compressor |
Cited By (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01128121U (en) * | 1988-02-26 | 1989-09-01 | ||
JP2005168723A (en) * | 2003-12-10 | 2005-06-30 | Nissei Kk | Absorbent adhesive sheet |
JP2008212591A (en) * | 2007-02-28 | 2008-09-18 | Chuichi Kubo | Wound protecting and dressing material |
US10299966B2 (en) | 2007-12-24 | 2019-05-28 | Kci Usa, Inc. | Reinforced adhesive backing sheet |
US10010656B2 (en) | 2008-03-05 | 2018-07-03 | Kci Licensing, Inc. | Dressing and method for applying reduced pressure to and collecting and storing fluid from a tissue site |
US12097094B2 (en) | 2008-03-05 | 2024-09-24 | Solventum Intellectual Properties Company | Dressing and method for applying reduced pressure to and collecting and storing fluid from a tissue site |
US11020516B2 (en) | 2008-03-05 | 2021-06-01 | Kci Licensing, Inc. | Dressing and method for applying reduced pressure to and collecting and storing fluid from a tissue site |
US10279088B2 (en) | 2010-03-16 | 2019-05-07 | Kci Licensing, Inc. | Delivery-and-fluid-storage bridges for use with reduced-pressure systems |
US20140330227A1 (en) | 2010-03-16 | 2014-11-06 | Kci Licensing, Inc. | Delivery-and-fluid-storage bridges for use with reduced-pressure systems |
US11400204B2 (en) | 2010-03-16 | 2022-08-02 | Kci Licensing, Inc. | Delivery-and-fluid-storage bridges for use with reduced-pressure systems |
US10568767B2 (en) | 2011-01-31 | 2020-02-25 | Kci Usa, Inc. | Silicone wound dressing laminate and method for making the same |
US10357406B2 (en) | 2011-04-15 | 2019-07-23 | Kci Usa, Inc. | Patterned silicone coating |
JP2015501671A (en) * | 2011-11-15 | 2015-01-19 | ケーシーアイ ライセンシング インコーポレイテッド | Medical dressings, systems, and methods with thermally enhanced vapor transmission |
US11944520B2 (en) | 2011-12-16 | 2024-04-02 | 3M Innovative Properties Company | Sealing systems and methods employing a hybrid switchable drape |
US10940047B2 (en) | 2011-12-16 | 2021-03-09 | Kci Licensing, Inc. | Sealing systems and methods employing a hybrid switchable drape |
US11969318B2 (en) | 2011-12-16 | 2024-04-30 | Solventum Intellectual Properties Company | Releasable medical drapes |
US9861532B2 (en) | 2011-12-16 | 2018-01-09 | Kci Licensing, Inc. | Releasable medical drapes |
US10945889B2 (en) | 2011-12-16 | 2021-03-16 | Kci Licensing, Inc. | Releasable medical drapes |
US11839529B2 (en) | 2012-11-16 | 2023-12-12 | Kci Licensing, Inc. | Medical drape with pattern adhesive layers and method of manufacturing same |
US11395785B2 (en) | 2012-11-16 | 2022-07-26 | Kci Licensing, Inc. | Medical drape with pattern adhesive layers and method of manufacturing same |
US10842707B2 (en) | 2012-11-16 | 2020-11-24 | Kci Licensing, Inc. | Medical drape with pattern adhesive layers and method of manufacturing same |
US10271995B2 (en) | 2012-12-18 | 2019-04-30 | Kci Usa, Inc. | Wound dressing with adhesive margin |
US11141318B2 (en) | 2012-12-18 | 2021-10-12 | KCl USA, INC. | Wound dressing with adhesive margin |
JP2015536795A (en) * | 2012-12-18 | 2015-12-24 | シスタジェニックス ウンド マネージメント イーペー カンパニー ベスローテン ヴェンノーツハップSystagenix Wound Management IP Co.B.V. | Wound dressing with adhesive rim |
US10946124B2 (en) | 2013-10-28 | 2021-03-16 | Kci Licensing, Inc. | Hybrid sealing tape |
US10940046B2 (en) | 2013-10-30 | 2021-03-09 | Kci Licensing, Inc. | Dressing with sealing and retention interface |
US10016544B2 (en) | 2013-10-30 | 2018-07-10 | Kci Licensing, Inc. | Dressing with differentially sized perforations |
US10849792B2 (en) | 2013-10-30 | 2020-12-01 | Kci Licensing, Inc. | Absorbent conduit and system |
US20150119831A1 (en) | 2013-10-30 | 2015-04-30 | Kci Licensing, Inc. | Condensate absorbing and dissipating system |
US9925092B2 (en) | 2013-10-30 | 2018-03-27 | Kci Licensing, Inc. | Absorbent conduit and system |
US11154650B2 (en) | 2013-10-30 | 2021-10-26 | Kci Licensing, Inc. | Condensate absorbing and dissipating system |
US9956120B2 (en) | 2013-10-30 | 2018-05-01 | Kci Licensing, Inc. | Dressing with sealing and retention interface |
US10967109B2 (en) | 2013-10-30 | 2021-04-06 | Kci Licensing, Inc. | Dressing with differentially sized perforations |
US10398814B2 (en) | 2013-10-30 | 2019-09-03 | Kci Licensing, Inc. | Condensate absorbing and dissipating system |
US11744740B2 (en) | 2013-10-30 | 2023-09-05 | Kci Licensing, Inc. | Dressing with sealing and retention interface |
US11793923B2 (en) | 2013-10-30 | 2023-10-24 | Kci Licensing, Inc. | Dressing with differentially sized perforations |
US12127917B2 (en) | 2014-03-03 | 2024-10-29 | Solventum Intellectual Properties Company | Low profile flexible pressure transmission conduit |
US11026844B2 (en) | 2014-03-03 | 2021-06-08 | Kci Licensing, Inc. | Low profile flexible pressure transmission conduit |
US10406266B2 (en) | 2014-05-02 | 2019-09-10 | Kci Licensing, Inc. | Fluid storage devices, systems, and methods |
US11957546B2 (en) | 2014-06-05 | 2024-04-16 | 3M Innovative Properties Company | Dressing with fluid acquisition and distribution characteristics |
US10561534B2 (en) | 2014-06-05 | 2020-02-18 | Kci Licensing, Inc. | Dressing with fluid acquisition and distribution characteristics |
US11246975B2 (en) | 2015-05-08 | 2022-02-15 | Kci Licensing, Inc. | Low acuity dressing with integral pump |
US11950984B2 (en) | 2015-09-01 | 2024-04-09 | Solventum Intellectual Properties Company | Dressing with increased apposition force |
US11096830B2 (en) | 2015-09-01 | 2021-08-24 | Kci Licensing, Inc. | Dressing with increased apposition force |
US10973694B2 (en) | 2015-09-17 | 2021-04-13 | Kci Licensing, Inc. | Hybrid silicone and acrylic adhesive cover for use with wound treatment |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS62275456A (en) | Wound protective material | |
US4977892A (en) | Wound dressing with hydrophilic absorbent layer | |
RU2597566C2 (en) | Superabsorbing thin adhesive bandage, its application in treating chronic injuries | |
US20170100504A1 (en) | Activated carbon containing wound dressing | |
EP2123309B1 (en) | Functional nano-layered hemostatic material/device | |
JP3575817B2 (en) | Extrudable compositions for topical or transdermal drug delivery | |
EP2578193B1 (en) | Surface sheet for wound dressing and wound dressing | |
JP4514955B2 (en) | Aseptic non-adhesive compressor | |
US5470576A (en) | Process for preparing the alginate-containing wound dressing | |
US3888247A (en) | First aid bandage | |
RU2715718C2 (en) | Wound dressing | |
JPH0261257B2 (en) | ||
JPH0798051B2 (en) | Roll-shaped wound protection material | |
JP2022523780A (en) | Antibacterial dressings, dressing components, and methods | |
AU602056B2 (en) | Polymeric wound dressings | |
JPS5957654A (en) | Low stickiness wound dressing | |
JP2017522137A (en) | 2-stage wound dressing assembly | |
JPS6340548A (en) | Dressing for wound, its production and use | |
Thomas | Low-adherence dressings | |
JPS6357046A (en) | Bandage for wound and its production | |
JP3308628B2 (en) | Medical patch | |
WO2009004282A2 (en) | Medical dressing | |
JPH0613821U (en) | Medical tape | |
JP3594364B2 (en) | Biocompatible adhesive pad and method for producing the same | |
JPH0649066B2 (en) | Medical adhesive sheet or tape |